Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is the third most common non-Hodgkin lymphoma subtype, accounting for around 6-8% of all non-Hodgkin lymphomas in the Western hemisphere. Although MALT lymphomas are clinically indolent, the disease is typically chronic, requiring long-term clinical surveillance and, often, repeated biopsies. Pathologists thus play a central role in the diagnosis and management of these patients. The optimal diagnosis and management of a MALT lymphoma requires careful integration of morphological, immunohistochemical and molecular information, together with close cooperation with the clinician treating the patient. This review discusses recent developments in the molecular pathogenesis of MALT lymphoma and provides strategies for integrating this information into daily pathological practice.
Bacon
Chris M
CM
Department of Pathology, University of Cambridge, Cambridge, UK.
Du
Ming-Qing
MQ
Dogan
Ahmet
A
D000465:Algorithms; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology; D018442:Lymphoma, B-Cell, Marginal Zone / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D011379:Prognosis; D012468:Salivary Gland Neoplasms / Q000473:pathology; D013274:Stomach Neoplasms / Q000473:pathology; D014178:Translocation, Genetic; D016896:Treatment Outcome